Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06577519
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-28
Brief Title:
Efficacy and Safety Study of Vicagrel in Patients With Acute Coronary Syndrome ACS Undergoing Percutaneous Coronary Intervention PCI
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Efficacy and Safety of Vicagrel in Patients With With Acute Coronary Syndrome ACS Undergoing Percutaneous Coronary Intervention PCI a Multi-center Randomized Double-blind Double-dummy Parallel-controlled Phase III Trial
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a multi-center randomized double-blind double-dummy parallel-controled phase III trial aiming to evaluate the effectiveness and safety of long-term continuous administration of Vicagrel capsules in ACS patients undergoing PCI
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None